September 19, 2021
Company Info
| Industry | Medical Specialties |
|---|---|
| Sector | Health Technology |
| Employees | 18,070 |
| CEO | Mr. Joseph M. Hogan |
| Address | 410 North Scottsdale Road Suite 1300, Tempe, AZ 85281 |
|---|---|
| Phone | 1.408.470.1000 |
| Website | www.aligntech.com |
Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and vivera retainers for treating malocclusion. The Scanner and Services segment comprises of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| Align Technology, Inc. | 17.29% | 119.30% |
| Novo Nordisk A/S | 22.52% | 45.77% |
| Danaher Corp. | 26.24% | 56.66% |
| Abbott Laboratories | 13.58% | 18.87% |
| Eli Lilly & Co. | 3.55% | 50.91% |
Statement Summary
as of 4:00 ET PM 09/16/2021| Total Assets (MRQ) | 5.4 B |
|---|---|
| Total Liabilities (MRQ) | 2.0 B |
| Shareholders’ Equity (MRQ) | 3.4 B |
| Total Revenue (Annual) | 1.0 B |
| Net Income (Annual) | 199.7 M |
Earnings And Estimates
as of 4:00 ET PM 09/16/2021
| Current Qtr EPS Estimate | 2.60 |
|---|---|
| Current FY EPS Estimate | 10.97 |
| Long Term EPS Growth Estimate | 24.70 |
| Next Expected Earnings Date | // |
ALGN vs S&P 500
as of 09/16/2021| Relative To S&P 500 |
ALGN | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:00 ET PM 09/16/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/2021 | 2.52 | 3.04 | +20.46% |
| 03/2021 | 2.02 | 2.49 | +23.14% |
| 12/2020 | 2.14 | 2.61 | +21.94% |
| 09/2020 | 0.64 | 2.25 | +254.16% |
| 06/2020 | -0.01 | -0.35 | +2,768.62% |
| 03/2020 | 1.09 | 0.73 | -33.17% |
| 12/2019 | 1.39 | 1.73 | +24.41% |
| 09/2019 | 1.14 | 1.28 | +12.71% |
Financial Strength
as of 4:00 ET PM 09/16/2021| Pre-Tax Margin | 26.59 |
|---|---|
| Net Margin | 0.00 |
| Operating Margin | 26.60 |
| Return On Equity | 22.42 |
| Return On Assets | 14.83 |
| Inventory Turnover (TTM) | 5.67 |
| Sales Growth (MRQ) | 23.73 |
Ratios
as of 4:00 PM ET 09/16/2021| Price/Earnings (TTM) | 80.91 |
|---|---|
| Price/Book (MRQ) | 16.78 |
| Price/Cash Flow (TTM) | 50.38 |
| Book Value (MRQ) | 42.87 |
| Quick Ratio (MRQ) | 1.21 |
| Current Ratio (MRQ) | 1.32 |
| Total Debt/Equity (MRQ) | 0.03 |
Short Interest
as of 4:00 PM ET 09/17/2021| % Short - 0.00% | |
| % Remaining Float - 100.00% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | n/a | n/a |
| Short Interest Shares | 0 | 0 |
| Short Interest Ratio | 0.0 | 0.0 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:00 ET PM 09/16/2021| Current Qtr (09/2021) |
Next Qtr (12/2021) |
|
|---|---|---|
| Consensus Estimate | $2.60 | $2.86 |
| # of Estimates | 14 | 14 |
| High Estimate | $2.80 | $3.14 |
| Low Estimate | $2.45 | $2.69 |
| Year Ago EPS | $1.77 | $2.02 |
| Year Over Year Growth Estimate | 46.97% | 41.72% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $10.97 | $13.35 |
| # of Estimates | 16 | 16 |
| High Estimate | $11.45 | $14.43 |
| Low Estimate | $10.10 | $12.90 |
| Year Ago EPS | $5.25 | $10.97 |
| Year Over Year Growth Estimate | 108.91% | 21.73% |
| Current Qtr (09/2021) |
Next Qtr (12/2021) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $2.60 | $2.86 | $10.97 | $13.35 |
| # of Estimates | 14 | 14 | 16 | 16 |
| High Estimate | $2.80 | $3.14 | $11.45 | $14.43 |
| Low Estimate | $2.45 | $2.69 | $10.10 | $12.90 |
| Year Ago EPS | $1.77 | $2.02 | $5.25 | $10.97 |
| Year Over Year Growth Estimate | 46.97% | 41.72% | 108.91% | 21.73% |
Insider Information Summary
as of 08/31/2021| % Insiders - 6.80% | |
| % Remaining Total Shares - 93.20% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | -42.07 K | 47.23 K |
| Shares Bought | 130.01 K | 143.14 K |
| Shares Sold | 172.08 K | 95.91 K |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
LATEST NEWS
Latest News
Align Technology Gets Strong Analyst Reviews After Earnings
- Apr 29, 2021 2:24 PM EDT
Stock Market Friday: Capital Gains Tax News Is an Opportunity
- Apr 23, 2021 10:56 AM EDT
'Mad Money' Lightning Round: UnitedHealth or Oscar Health?
- Apr 23, 2021 10:20 AM EDT
Rate Rumble: Cramer's 'Mad Money' Recap (Thursday 2/25/21)
- Feb 25, 2021 8:16 PM EST
Back to Basics: Cramer's 'Mad Money' Recap (Wednesday 2/24/21)
- Feb 24, 2021 9:34 PM EST
10 Best Stocks in the Nasdaq This Past Week: Moderna Climbs
- Nov 30, 2020 8:58 AM EST
Darling Ingredients, Align Technology: 5 Top Stock Gainers for Thursday
- Oct 22, 2020 1:25 PM EDT
Align Technology Soars as Analysts Rave About Third-Quarter Earnings
- Oct 22, 2020 9:57 AM EDT
Aging Bull: Cramer's 'Mad Money' Recap (Thursday 4/30/20)
- Apr 30, 2020 8:43 PM EDT
Recent Articles from TheStreet
Cramer: Using Short-Term Moves to Tweak Your Portfolio
Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.
Jensen: These Three Healthcare Stocks Are Worth a Look
Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.
Parus Files Second Patent Infringement Lawsuit Against Apple
Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.
Business Software Provider AvidXchange Files for IPO
Accounts payable software provider AvidXchange on Friday filed for a initial public offering.
Intraday Reversals Signal Struggles for Market
But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.
Cramer's Mad Money Recap: FedEx, Costco, Nike
Jim Cramer says this is a rough season for stock, and investors need to take defensive action.
Jensen: Economy Has a Bearish Outlook
Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.
FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk
Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.
Stock Market Today With Jim Cramer: How to Trade Ford
Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.
CLOSE
CLOSE
CLOSE
CLOSE